Francisco López‐Medrano
- Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments 21
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies 14
- Epidemiology top 1%
- Cytomegalovirus and herpesvirus research 41
- Influenza Virus Research Studies 25
- Pneumocystis jirovecii pneumonia detection and treatment 25
- Respiratory viral infections research 24
- Infective Endocarditis Diagnosis and Management 20
- Herpesvirus Infections and Treatments 14
- Molecular Medicine top 2%
- Co-authors
- José María AguadoRafael San JuanMario Fernández‐RuizCarlos LumbrerasManuel LizasoaínAmado AndrésAsunción MorenoAntonio Lalueza
- Journals
- SHILAP Revista de lepidopterología (1 paper)Clinical Infectious Diseases (8 papers)Scientific Reports (1 paper)
- Partner nations
- SpainUnited StatesSwitzerland
In The Last Decade
Francisco López‐Medrano
194 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 126
- Transplantation 532
- Applied Microbiology and Biotechnology 184
- Infectious Diseases 1.5k
- Epidemiology 2.4k
- Molecular Medicine 205
Countries citing papers authored by Francisco López‐Medrano
This map shows the geographic impact of Francisco López‐Medrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco López‐Medrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco López‐Medrano more than expected).
Fields of papers citing papers by Francisco López‐Medrano
This network shows the impact of papers produced by Francisco López‐Medrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco López‐Medrano. The network helps show where Francisco López‐Medrano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francisco López‐Medrano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 20 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 19 | |
| 18 | 2019 | 7 | |
| 19 | 2011 | 30 | |
| 20 | Utilidad de la amfotericina B liposomal para la prevención de la infección fúngica en receptores de un trasplante de órgano sólido | 2005 | 2 |
About Francisco López‐Medrano
Francisco López‐Medrano is a scholar working on Transplantation, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 213 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (41 papers), Influenza Virus Research Studies (25 papers), Pneumocystis jirovecii pneumonia detection and treatment (25 papers), Respiratory viral infections research (24 papers), Renal Transplantation Outcomes and Treatments (21 papers), Infective Endocarditis Diagnosis and Management (20 papers), Herpesvirus Infections and Treatments (14 papers) and COVID-19 Clinical Research Studies (14 papers). The work is most often cited by research in Transplantation (532 citations), Applied Microbiology and Biotechnology (184 citations) and Infectious Diseases (1.5k citations). Francisco López‐Medrano has collaborated with scholars based in Spain, United States and Switzerland. Frequent co-authors include José María Aguado, Rafael San Juan, Mario Fernández‐Ruiz, Carlos Lumbreras, Manuel Lizasoaín, Amado Andrés, Asunción Moreno, Antonio Lalueza, Jordi Carratalà and Natalia Polanco. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.